Komatsu, Y., Ishioka, C., Shimada, K., Yamada, Y., Gamoh, M., Sato, A., . . . Kurihara, M. (2015). Study protocol of the TRICOLORE trial: A randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer. BMC Cancer.
Citação norma ChicagoKomatsu, Yoshito, et al. "Study Protocol of the TRICOLORE Trial: A Randomized Phase III Study of Oxaliplatin-based Chemotherapy Versus Combination Chemotherapy With S-1, Irinotecan, and Bevacizumab As First-line Therapy for Metastatic Colorectal Cancer." BMC Cancer 2015.
Citação norma MLAKomatsu, Yoshito, et al. "Study Protocol of the TRICOLORE Trial: A Randomized Phase III Study of Oxaliplatin-based Chemotherapy Versus Combination Chemotherapy With S-1, Irinotecan, and Bevacizumab As First-line Therapy for Metastatic Colorectal Cancer." BMC Cancer 2015.